Converts hydrogen fluoride into refrigerants and pharmaceutical ingredients inside China's domestic fluorspar supply chain.
At a glance
Depends onDownstream position: depends on 12 industries, supplies 4
Scale
Market cap is above the global median
PositionGross margin is in the top 5% of Chemicals peers
Interpretations11 currently firing — 2 · 9
What this company is and how it runs — written from structure, not news.
Nature view
Zhejiang Sanmei Chemical Industry converts hydrogen fluoride into refrigerants and pharmaceutical intermediates at its Zhejiang facilities, sitting at the end of a supply chain that runs from fluorspar mines in Inner Mongolia and Hunan Province through domestic acid producers before any international buyer can access the same feedstock. Because hydrogen fluoride destroys ordinary steel and glass, the Hastelloy reactors and PTFE-lined systems required to handle it represent years of capital spending and operational knowledge that a new competitor cannot assemble quickly even if money is available. Once a pharmaceutical customer qualifies Sanmei's product after 18 to 24 months of regulatory testing, restarting that clock with a different supplier is costly enough that the revenue effectively locks in place. The entire structure depends on China's domestic fluorspar and hydrogen fluoride supply remaining open — if export restrictions or environmental enforcement curtail mining output in those two provinces, the geographic proximity that eliminates import costs disappears for Sanmei on exactly the same terms as it does for everyone else.
How does this company make money?
The company charges per kilogram of fluorinated product sold, with the base price tied to what fluorspar and hydrogen fluoride cost as raw materials. Customers who need pharmaceutical-grade purity pay a premium above that base rate. The company also earns fees for custom fluorination chemistry work done to a specific customer's requirements.
What makes this company hard to replace?
Pharmaceutical customers must run 18 to 24 months of regulatory validation before they can accept a fluorinated intermediate from a new supplier — once this company's product is qualified, switching means starting that entire clock again. HVAC manufacturers who have signed long-term supply agreements face extensive equipment revalidation before they could use a different refrigerant. Customers also build their handling and storage infrastructure around specific product specifications, so even the physical setup at their own facilities pushes against switching.
What limits this company?
The company can only run as fast as domestic Chinese acid producers can deliver hydrogen fluoride. Fluorspar mining is concentrated in Inner Mongolia and Hunan, and the corridor moving ore to acid plants to Zhejiang has a fixed ceiling. Adding more reactor trains at the Zhejiang site does not help if the hydrogen fluoride supply is not there to feed them.
What does this company depend on?
The company cannot run without fluorspar concentrate from Chinese mining operations, hydrogen fluoride from domestic acid producers, and chloroform and methylene chloride from petrochemical complexes. It also depends on corrosion-resistant alloy suppliers for specialized Hastelloy reactor equipment and on Zhejiang provincial authorities for the environmental discharge permits that allow the facilities to operate.
Who depends on this company?
Automotive air conditioning manufacturers depend on its R-134a refrigerant — if supply is interrupted, their production lines stop. Pharmaceutical companies making metered-dose inhalers rely on its fluorinated propellants, and a shortage halts inhaler assembly. Electronics manufacturers use its fluorinated solvents to clean sensitive components, and switching to substitute solvents risks damaging the parts.
How does this company scale?
Batch reaction improvements and heat-recovery systems can be copied across additional reactor trains at the same Zhejiang site, which brings down the energy cost of each kilogram produced. What does not scale easily is the hydrogen fluoride handling expertise and the specialized metallurgy knowledge — both take years of operational experience to develop safely, so every new reactor train still depends on a team that knows how to manage corrosive chemistry without incident.
What external forces can significantly affect this company?
The Montreal Protocol requires the world to phase down high-GWP fluorocarbons, which pushes refrigerant customers toward lower-GWP alternatives that need different production chemistry. European F-gas regulations are accelerating that demand shift. U.S.-China trade tensions create uncertainty around fluorochemical tariff structures, which can change what customers in those markets are willing to pay or buy.
Where is this company structurally vulnerable?
If Chinese authorities restricted exports of fluorspar or hydrogen fluoride — or if environmental enforcement in Inner Mongolia sharply reduced mining output — the supply-chain closeness that gives this company its cost and speed advantage would disappear. The same geographic concentration that eliminates import logistics for the company is also the single point that, if cut, leaves it no better off than a competitor starting from scratch.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Multi-Year Up-Close-Week Share With Profitability And Book-Value Growth
Three observations describe the present configuration: a high share of the trailing three years' weekly closes were higher than the prior week, the company has reported positive net income in each of the last five annual periods, and the book-value-increase-consistency composite over the trailing 5 years is elevated.
Reads
One-Year Up-Close-Week Share With Profitability And OCF Margin
Three observations describe the present configuration: a high share of the trailing year's weekly closes were higher than the prior week, the company has reported positive net income in each of the last three annual periods, and the industry-benchmarked TTM operating cash flow margin is in the upper peer range.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.97%Above 5Y avg (0.75%)
Annual Rate
CNY 1.20Paid annual
Payout Ratio
21.6%Sustainable
Payback Period
50.1 yr
Last Ex-Dividend
Jun 4, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
37.10BCNY
vs all stocks (USD)
Updated Jul 16, 2026
Trailing P/E
17.79x
vs Chemicals peers
Updated Jul 16, 2026
Revenue (TTM)
6.04BCNY
vs all stocks (USD)
Updated Jul 16, 2026
Profit Margin
35.89%
vs Chemicals peers
Updated Jul 16, 2026
Beta
0.6430x
vs all stocks
Updated Jul 16, 2026
52-Week Change
30.67%
vs all stocks
Updated Jul 16, 2026
Market Capitalization
37.10BCNY
vs all stocks (USD)
Updated Jul 16, 2026
Enterprise Value
35.48BCNY
vs all stocks (USD)
Updated Jul 16, 2026
Trailing P/E
17.79x
vs Chemicals peers
Updated Jul 16, 2026
Gross Margin
53.42%
vs Chemicals peers
Updated Jul 16, 2026
Profit Margin
35.89%
vs Chemicals peers
Updated Jul 16, 2026
Operating Margin
44.42%
vs Chemicals peers
Updated Jul 16, 2026
Shares Outstanding
610.48MSharesUpdated Jul 16, 2026
Float Shares
228.94MSharesUpdated Jul 16, 2026
% Held by Insiders
62.05%
vs all stocks
Updated Jul 16, 2026
% Held by Institutions
8.14%
vs all stocks
52-Week Low
44.81CNYUpdated Jul 16, 2026
52-Week High
87.20CNYUpdated Jul 16, 2026
52-Week Change
30.67%
vs all stocks
Updated Jul 16, 2026
Beta
0.6430x
vs all stocks
Updated Jul 16, 2026
9 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Cash Elevated Relative to Current Liabilities and Total Assets
Two cash observations have aligned: the cash ratio (cash divided by current liabilities) is in the upper industry-benchmarked range, and cash represents a meaningful share of total assets.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Three observations have aligned: most-recent-quarter total cash is in the upper portion of its mapped range against most-recent-quarter total debt, EBITDA-to-total-liabilities is in the upper portion of its mapped range, and FCF-to-total-liabilities is in the upper portion of its mapped range.
Reads
Liquidity Ratios Elevated
Three liquidity ratios co-occur in their elevated ranges: current ratio (industry-benchmarked), quick ratio, and cash ratio. The simultaneous firing means coverage is elevated through progressively more liquid asset layers, not concentrated in inventory or receivables.
Reads
Low-Leverage Liquidity Configuration
Three balance-sheet observations co-occur: industry-benchmarked current ratio elevated, industry-benchmarked equity ratio elevated, and total cash at MRQ at least equal to total debt. The configuration describes equity-heavy capital structure with cash covering total debt.
Reads
How does this company use capital?
Industry-Benchmarked Margin Stack
Three margin observations have aligned: industry-benchmarked gross profit margin is in the upper peer range, operating income margin is in the upper portion of its mapped range, and industry-benchmarked TTM operating cash flow margin is in the upper peer range.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Three margin observations have aligned: industry-benchmarked gross profit margin is in the upper peer range, operating income margin is in the upper portion of its mapped range, and industry-benchmarked net profit margin is in the upper peer range.
Reads
ROE, ROA, And Operating ROA Elevated
Three industry-benchmarked return-on-capital ratios are simultaneously in their elevated ranges: ROE, ROA, and operating ROA. Because ROA and operating ROA both fire alongside ROE, the configuration is not solely a function of equity multiplier; the underlying asset base is also producing elevated returns relative to peers.
Reads
Is this company growing?
Earnings, Profit, and Cash Flow All Compounding
Three profitability lines have aligned at positive 4-year CAGR: net income growth, gross profit growth, and free cash flow growth. Together they describe consistent compound growth across the income statement and cash flow statement.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Retained earnings are a large share of total assets; net income was positive in each of the last 5 fiscal years; shareholders' equity is in the upper part of its industry's equity-to-assets range.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is in the top 5% of Chemicals peersSignificant
Gross margin: 0.53Industry P95: 0.45
Operating margin is in the top 5% of Chemicals peersSignificant
Operating margin: 0.44Industry P95: 0.29
Profit margin is in the top 5% of Chemicals peersSignificant
Profit margin: 0.36Industry P95: 0.31
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 1.13
Supply Chain
Downstream position: depends on 12 industries, supplies 4Notable
Outgoing: 4.00Incoming: 12.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Market cap is above the global medianNotable
Market cap (USD): 5,477,056,631.275Global Median: 1,131,844,382.907
Industry-Benchmarked Margin StackMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityMulti-Year Up-Close-Week Share With Profitability And Book-Value GrowthCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedOne-Year Up-Close-Week Share With Profitability And OCF MarginThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity Configuration
Industry-Benchmarked Margin StackMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityMulti-Year Up-Close-Week Share With Profitability And Book-Value GrowthCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity ConfigurationEarnings, Profit, and Cash Flow All Compounding